The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
XtalPi announced an expansion of its research collaboration with Pfizer to pioneer a next-generation molecular modeling platform for drug discovery. ...
read more
Halozyme Therapeutics announced that Bristol Myers Squibb received European Commission (EC) approval of a new Opdivo® (nivolumab) subcutaneous ...
read more
The FDA has approved Brekiya (dihydroergotamine mesylate) injection, marking a significant advancement in the acute treatment of migraine and cluster ...
read more
Eascra Biotech, a nanomedicine startup, has been awarded a $100,000 Stage I SBIR Targeted Technologies (START) grant funded by the Commonwealth and ...
read more
Colorcon has announced an exclusive partnership with ASHA Cellulose, a provider of organo-soluble Ethyl cellulose polymers widely used in the ...
read more
Signios Biosciences announced its rebranding from its previous identity as the US based research division of MedGenome Inc. This milestone marks a new...
read more
Wednesday, April 09, 2025
Orexo AB announced positive in-vivo proof-of-concept data for a powder-based intranasal vaccine candidate formulated with the AmorphOX technology.
read more
Wednesday, March 26, 2025
GV20 Therapeutics (GV20) has entered into a strategic research collaboration with Mitsubishi Tanabe Pharma Corporation (MTPC). Under this ...
read more
Wednesday, February 26, 2025
ImmunoPrecise Antibodies Ltd. (IPA) announced a strategic collaboration with RIBOPRO, a provider of mRNA and lipid nanoparticle (LNP) technologies. ...
read more
Thursday, January 30, 2025
Breckenridge Pharmaceutical, Inc., announced that the Food and Drug Administration (FDA) has granted final approval of Everolimus Tablets for Oral ...
read more
Wednesday, January 29, 2025
Ocean Biomedical announced that its Scientific Co-founder, Dr. Jonathan Kurtis, MD, PhD, and his research team have received additional significant ...
read more
Thursday, January 16, 2025
Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved Omvoh® (mirikizumab-mrkz) for the treatment of ...
read more
Wednesday, January 15, 2025
The FDA’s Rare Disease Innovation Hub (the Hub) has released its Strategic Agenda, which outlines the actions the Hub plans to undertake during its ...
read more
Thursday, January 09, 2025
Oxford BioTherapeutics announced that Boehringer Ingelheim has exercised an option for rights to a fourth novel oncology target from an ongoing ...
read more
Wednesday, January 08, 2025
Merck announced that the National Medical Products Administration (NMPA) of China approved GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, ...
read more